Gossamer Bio USA clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801Gereic Dry Powder Inhaler, SeralutinibRecruiting2026-12Estimated

Phase 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Actual. After: Estimated.

Enrollment · participant count changed

Before: 316 participants (actual). After: 330 participants (planned).

Recruitment status changed

Before: Active not recruiting. After: Recruiting.

Check registry source

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 300 participants (planned). After: 316 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source